SCHEMBL14342967

SCHEMBL14342967

Nc1ccc2c(c1)Cc1cc(Oc3ccc4c(c3)Cc3cc(Oc5ccc6c(c5)Cc5cc(N)ccc5-6)ccc3-4)ccc1-2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.60
▸ MAPT P10636 4/20 0.60
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ LMNA P02545 3/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ TLR9 Q9NR96 1/20 0.50
▸ GAA P10253 2/20 0.45
▸ MITF O75030 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ NLRP1 Q9C000 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ CYP3A4 P08684 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14343044 0.92 ALDH1A1 (0.56) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14343002 0.92 ALDH1A1 (0.56) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14343201 0.91 ALDH1A1 (0.50) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14342988 0.88 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14343109 0.87 ALDH1A1 (0.50) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14342999 0.87 MAOB (0.58) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL123584 0.85 RAB9A (0.78) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL29372630 0.85 RAB9A (0.78) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
SCHEMBL14343130 0.83 ALDH1A1 (0.46) ALDH1A1MAPTSMN1; SMN2LMNARAB9A
Hydrochloric Acid SCHEMBL17417855 0.83 RAB9A (0.75) ALDH1A1MAPTSMN1; SMN2LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2692775-B1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE- ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORP (JP) 2015-04-08 — — EP disclosed
US-20140235896-A1 NOVEL DIAMINE COMPOUND NITTO DENKO CORPORATION (JP) 2014-08-21 — — US disclosed
US-8748664-B2 Diamine compound and production method thereof NITTO DENKO CORPORATION (JP) 2014-06-10 — — US disclosed
EP-2692775-A1 POLYIMIDE, POLYIMIDE POLYMER ELECTROLYTE MEMBRANE, MEMBRANE ELECTRODE ASSEMBLY, AND SOLID POLYMER FUEL CELL Nitto Denko Corporation (JP) 2014-02-05 — — EP disclosed
US-20130171541-A1 POLYIMIDE, POLYIMIDE-BASED POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL NITTO DENKO CORPORATION (JP) 2013-07-04 — — US disclosed
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF NITTO DENKO CORPORATION (JP) 2013-01-03 — — US disclosed
EP-2540699-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF Nitto Denko Corporation (JP) 2013-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130006017-A1 NOVEL DIAMINE COMPOUND AND PRODUCTION METHOD THEREOF AOC1, SAT1, ODC1 ALDH1A1 100/4885MAPT 2105/4885SMN1; SMN2 1987/4885
US-20140235896-A1 NOVEL DIAMINE COMPOUND AOC1, SAT1, ARG1 ALDH1A1 55/4885MAPT 2060/4885SMN1; SMN2 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback